Arun Nagdev Joins Butterfly Network as Chief Medical Officer – POCUS

Butterfly Network has appointed Arun Nagdev, M.D., as chief medical officer – Point-of-Care Ultrasound (POCUS). He will lead the global medical strategy for the company’s core POCUS business, striving to advance clinical product validation, strengthen customer engagement, and support regulatory and clinical development efforts.

Dr. Nagdev has more than 20 years of experience advancing POCUS adoption, education, and clinical standards worldwide. He is currently as an attending physician and director of Emergency Ultrasound at Highland General Hospital and an associate clinical professor of Emergency Medicine at the University of California, San Francisco. He has also held national leadership roles within professional organizations, including the American College of Emergency Physicians and the American Institute of Ultrasound in Medicine.

“Arun is one of the most respected voices in point-of-care ultrasound, with a rare combination of clinical credibility, academic leadership, and product insight,” Butterfly Network President/CEO/Chairman Joseph DeVivo said. “As we continue to scale our enterprise strategy and expand globally, his leadership will be critical to ensuring our technology delivers measurable clinical and economic value for customers.”

In addition to his clinical and academic leadership, Dr. Nagdev has acquired deep experience at the intersection of ultrasound, artificial intelligence, and product development. He previously served as vice president of Clinical at Exo and has advised global imaging companies including Philips and Fujifilm SonoSite. He is also a widely published researcher and educator, with an influential body of peer-reviewed research and invited presentations worldwide.

“Butterfly has fundamentally changed what’s possible with ultrasound through its semiconductor-based, software-defined platform,” Dr. Nagdev stated. “I’m excited to join at a time when point-of-care ultrasound is becoming essential to care delivery across settings. The next phase will be defined by clinical standards and broader adoption, and I look forward to supporting that progression globally.”

Butterfly Network Inc. is a healthcare company driving a digital revolution in medical imaging with its proprietary Ultrasound-on-Chip semiconductor technology and ultrasound software solutions. In 2018, Butterfly launched the world’s first handheld, single-probe, whole-body ultrasound system, Butterfly iQ. The iQ+ followed in 2020, and the iQ3 in 2024, each with improved processing power and performance by leveraging Moore’s Law. The iQ3 earned Best Medical Technology at the 2024 Prix Galien USA Awards. Butterfly’s innovations have also been recognized by Fierce 50, TIME’s Best Inventions and Fast Company’s World Changing Ideas, among other achievements.

Butterfly combines advanced hardware, intelligent software, AI, services, and education to drive adoption of affordable, accessible imaging. Clinical publications demonstrate that its handheld ultrasound probes, paired with Compass enterprise workflow software, can help hospital systems improve care workflows, reduce costs, and enhance provider economics. With a cloud-based solution that enables care anywhere through next-generation mobility, Butterfly aims to democratize healthcare by addressing critical global healthcare challenges. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America, and South America.